Laxmi Organic Industries Ltd
Laxmi Organic Industries Limited was established in 1989 and is in the business of specialty chemicals. The Company primarily manufactures Ethyl Acetate, Acetic Acid and Diketene Derivative Products (DDP). DDP is a specialty chemical group, the technology and business of which has been acquired by the company from Clariant Chemicals India Limited.
The company’s business operations are carried in over 30 countries including 11 offices located in India
- Market Cap ₹ 6,802 Cr.
- Current Price ₹ 246
- High / Low ₹ 326 / 220
- Stock P/E 50.8
- Book Value ₹ 67.1
- Dividend Yield 0.24 %
- ROCE 9.40 %
- ROE 7.36 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company's working capital requirements have reduced from 49.0 days to 23.6 days
Cons
- Company has a low return on equity of 12.1% over last 3 years.
- Dividend payout has been low at 10.5% of profits over last 3 years
- Promoter holding has decreased over last 3 years: -3.42%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chemicals
Part of BSE 250 SmallCap Index BSE Allcap BSE Commodities BSE 400 MidSmallCap Index BSE SmallCap
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|
1,074 | 1,047 | 1,076 | 1,376 | 1,569 | 1,534 | 1,768 | 3,084 | 2,791 | 2,863 | 2,975 | |
988 | 966 | 957 | 1,222 | 1,414 | 1,418 | 1,548 | 2,713 | 2,548 | 2,605 | 2,688 | |
Operating Profit | 86 | 80 | 119 | 154 | 155 | 117 | 220 | 371 | 243 | 259 | 287 |
OPM % | 8% | 8% | 11% | 11% | 10% | 8% | 12% | 12% | 9% | 9% | 10% |
1 | 2 | 2 | 3 | 6 | 30 | 4 | 15 | 18 | 28 | 33 | |
Interest | 26 | 19 | 11 | 12 | 19 | 17 | 19 | 19 | 15 | 9 | 11 |
Depreciation | 30 | 29 | 28 | 31 | 44 | 49 | 47 | 48 | 72 | 107 | 111 |
Profit before tax | 31 | 34 | 82 | 113 | 98 | 81 | 158 | 319 | 173 | 171 | 198 |
Tax % | 31% | 22% | 13% | 33% | 26% | 13% | 20% | 19% | 28% | 29% | |
21 | 27 | 72 | 76 | 72 | 70 | 127 | 257 | 125 | 121 | 134 | |
EPS in Rs | 21.12 | 26.56 | 71.50 | 75.63 | 14.46 | 15.57 | 4.82 | 9.76 | 4.70 | 4.37 | 4.86 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 11% | 10% | 7% | 11% | 14% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 13% |
3 Years: | 17% |
TTM: | 8% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 10% |
3 Years: | -2% |
TTM: | 33% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -16% |
1 Year: | -8% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 13% |
3 Years: | 12% |
Last Year: | 7% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 10 | 10 | 10 | 10 | 50 | 45 | 53 | 53 | 53 | 55 | 56 |
Reserves | 199 | 225 | 295 | 369 | 400 | 382 | 982 | 1,237 | 1,359 | 1,742 | 1,800 |
249 | 221 | 104 | 215 | 175 | 159 | 149 | 139 | 406 | 143 | 200 | |
152 | 176 | 240 | 300 | 389 | 484 | 654 | 820 | 595 | 887 | 771 | |
Total Liabilities | 610 | 632 | 649 | 895 | 1,014 | 1,069 | 1,838 | 2,249 | 2,412 | 2,827 | 2,828 |
226 | 215 | 202 | 293 | 346 | 338 | 325 | 379 | 715 | 879 | 904 | |
CWIP | 25 | 40 | 61 | 30 | 31 | 67 | 148 | 374 | 447 | 444 | 502 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 5 | 23 | 126 | 192 |
358 | 377 | 386 | 571 | 637 | 664 | 1,361 | 1,492 | 1,228 | 1,378 | 1,231 | |
Total Assets | 610 | 632 | 649 | 895 | 1,014 | 1,069 | 1,838 | 2,249 | 2,412 | 2,827 | 2,828 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
80 | 150 | -7 | 188 | 196 | 106 | 65 | 199 | 562 | ||
-21 | -37 | -85 | -123 | -56 | -641 | 76 | -384 | -490 | ||
-57 | -107 | 85 | -63 | -123 | 527 | -124 | 232 | -42 | ||
Net Cash Flow | 1 | 6 | -7 | 2 | 16 | -7 | 17 | 47 | 30 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 64 | 67 | 79 | 86 | 76 | 86 | 90 | 79 | 75 | 74 |
Inventory Days | 37 | 57 | 37 | 55 | 57 | 51 | 63 | 64 | 58 | 54 |
Days Payable | 52 | 67 | 85 | 81 | 105 | 138 | 148 | 122 | 92 | 145 |
Cash Conversion Cycle | 49 | 56 | 30 | 60 | 28 | -1 | 5 | 21 | 41 | -16 |
Working Capital Days | 65 | 66 | 36 | 65 | 43 | 25 | 27 | 58 | 66 | 24 |
ROCE % | 12% | 22% | 25% | 19% | 12% | 20% | 26% | 12% | 9% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
14 Nov - Confirmation of no deviation in QIP proceeds utilization.
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
14 Nov - Confirmation of no deviation in IPO proceeds utilization.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
6 Nov - The officials of the Company will be meeting Investors/ Analysts (Participants) on 22nd November 2024 at Midcap Conference hosted by Kotak Securities.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
6 Nov - The officials of the Company will be meeting Investors/ Analysts (Participants) on 13th November 2024 at an Annual Investor Conference hosted by Avendus Spark.
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
4 Nov - Laxmi Organic Industries Limited has submitted the Transcript of the Investor & Analyst meet held to discuss the performance for the quarter ended September 30, …
Annual reports
Concalls
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
Jul 2024TranscriptNotesPPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT
-
Oct 2023Transcript PPT REC
-
Oct 2023TranscriptNotesPPT
-
Aug 2023Transcript PPT
-
Jul 2023TranscriptNotesPPT
-
May 2023TranscriptPPT
-
May 2023Transcript PPT
-
Jan 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Nov 2022TranscriptNotesPPT
-
Aug 2022Transcript PPT
-
Jul 2022TranscriptNotesPPT
-
May 2022TranscriptNotesPPT
-
Feb 2022TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
May 2021Transcript PPT
Leadership[1]
Top supplier in India and amongst top 3 players globally (ex. China) in Essentials and among top 5 globally in Specialities.